Bronchodilators delivered via high-flow nasal cannula (HFNC) in adults with moderate-severe asthma exacerbation admitted to the emergency department (ED) - Milan 2023

Addressing exacerbations and pneumonia in airway diseases

Chair(s): Charlotte Suppli Ulrik, Sachin Ananth

Session type: Poster session

Bronchodilators delivered via high-flow nasal cannula (HFNC) in adults with moderate-severe asthma exacerbation admitted to the emergency department (ED)

Nicolas Colaianni Alfonso

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

A prospective study of inhaled therapy prescribing, pMDI technique assessment, and inhaler concordance amongst hospitalised patients with airways disease

Luanne Lai

Poster

Abstract

A Comparative Study to Evaluate the Efficacy/Outcome of Non-invasive Positive Pressure Ventilation through Mechanical Ventilator and conventional BiPAP in Patients of Hypercapnic Respiratory Failure

Aman Ahuja

Poster

Abstract

Tapering courses of oral corticosteroids after hospital admission due to asthma exacerbation

Richard Russell

Poster

Abstract

Inhaled versus systemic corticosteroids in COPD exacerbations: a meta-analysis.

Efthymia Papadopoulou

Poster

Abstract

A Simple Clinical Risk Score (A2CDPS) for Predicting Mortality in Patients with AECOPD and Cardiovascular Diseases

Jiarui Zhang

Poster

Abstract

Characteristics of exacerbations in patients with severe, uncontrolled asthma who received tezepelumab versus placebo

Arnaud Bourdin

Poster

Abstract

Validation of an EMR derived algorithm to identify moderate asthma exacerbations in the UK

Kieran J. Rothnie

Poster

Abstract

Bronchodilators delivered via high-flow nasal cannula (HFNC) in adults with moderate-severe asthma exacerbation admitted to the emergency department (ED)

Nicolas Colaianni Alfonso

Abstract

Increased risk of severe cardiovascular events following exacerbations of COPD: a multi-database cohort study

Claus Vogelmeier

Poster

Abstract

Systemic inflammation and exacerbations are associated with serum vitamin D levels in a cohort of patients with COPD, group E

Apostolos Sioutas

Abstract

Better Response to Tanreqing Injection in Frequent Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) Patients Real-World Evidence from a Nationwide Registry (ACURE) Study

Guohui Fan

Abstract

COPD Patients Admitted to Hospital: A Missed Opportunity to Optimise Care?

Alicia Piwko

Poster

Abstract

Inhaled corticosteroid might not affect clinical outcomes of pneumonia in patients with chronic obstructive pulmonary disease

Inso Cho

Poster

Abstract

One-year mortality and readmission rate following hospitalization for acute exacerbation of chronic obstructive pulmonary disease based on the types of acute respiratory failure

Hong-joon Shin

Poster

Abstract

FREQUENCY OF OCCURRENCE AND GENE-SEROTYPE CHARACTERISTIC OF STREPTOCOCCUS PNEUMONIAE IN COHORT OF PATIENTS WITH COPD.

Rano Nalibaeva

Poster

Abstract

Medical errors in the use of antibacterial drugs of the cephalosporin group at the outpatient stage of the treatment of respiratory pathology

Irina Liverko

Poster

Abstract

In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study

Lies Lahousse

Poster

Abstract

Interpreting the significance of collagen-IV level changes in bronchoalveolar fluid in acute COPD exacerbation before and after tiotropium bromide treatment

Mariana Kulynych-miskiv

Poster

Abstract

Respiratory specialist visit before admission with a COPD exacerbation may affect management and outcomes.

Ophir Freund

Poster

Abstract

Predictive factors for the occurrence of COPD exacerbations

Meriam Nemleghi

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}